About us
The Digital Health Validation Lab (DHVL) is dedicated to driving the future of healthcare by providing the critical infrastructure and expertise needed to thoroughly assess health technologies. Our mission is to accelerate the development and clinical adoption of pioneering solutions to better tackle critical healthcare challenges and improve patient outcomes.
Our multidisciplinary team, composed of leading academics and clinicians, is committed to integrating healthtech solutions into clinical practice ethically and responsibly. By providing specialist services throughout the product development lifecycle, we ensure that new technologies are safe, effective, and transformative for patients.
At DHVL, we foster a culture of innovation where cutting-edge technology meets rigorous evaluation, resulting in impactful and trustworthy solutions that have the potential to revolutionise healthcare.
Our Mission
Accelerate Innovation
Guiding innovators through rapid but thorough development and evaluation processes.
Increase Adoption
Supporting the adoption of effective technologies and methods into clinical settings.
Improve Health Outcomes
Collaborating to tackle the most critical healthcare challenges for the biggest impact.
How we can support you
Partnering with the Digital Health Validation Lab provides access to an unparalleled blend of expertise, resources, and strategic positioning to accelerate your healthtech innovation from concept or prototype to clinical adoption.
Located on one of Europe’s largest acute hospital sites
Our proximity to the Queen Elizabeth University Hospital campus – one of Europe’s largest acute hospital sites – allows us to engage with a diverse patient and clinician population. This is essential for conducting comprehensive patient and public involvement and engagement (PPIE) activities, focus groups, and clinical trials across a wide range of medical, surgical, and primary care specialties.
Support from an expert team
Our expert team, comprising leading academics from the University of Glasgow and experienced clinicians at the Queen Elizabeth University Hospital, brings a wealth of expertise in generating credible evidence that supports funding, regulatory, and adoption decisions. We have a strong track record in rigorously assessing a broad range of health technologies, including advanced AI solutions.
Collaborative network
We collaborate with NHS Greater Glasgow and Clyde to provide secure access to pseudonymised patient data and ensure seamless integration with trial approvals, sponsorship, and recruitment. Our strong partnership with the University of Glasgow's Health Economics and Health Technology Assessment (HEHTA) research group ensures comprehensive evaluation of the economic and clinical impact of your product, building trust among regulators and decision-makers.